Beta Bionics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Beta Bionics and other ETFs, options, and stocks.

About BBNX

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. 

CEO
Sean Thomas Saint
CEOSean Thomas Saint
Employees
291
Employees291
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2015
Founded2015
Employees
291
Employees291

BBNX Key Statistics

Market cap
1.32B
Market cap1.32B
Price-Earnings ratio
-16.74
Price-Earnings ratio-16.74
Dividend yield
Dividend yield
Average volume
730.14K
Average volume730.14K
High today
$31.51
High today$31.51
Low today
$29.56
Low today$29.56
Open price
$30.03
Open price$30.03
Volume
644.75K
Volume644.75K
52 Week high
$32.71
52 Week high$32.71
52 Week low
$8.89
52 Week low$8.89

Stock Snapshot

As of today, Beta Bionics(BBNX) shares are valued at $30.00. The company's market cap stands at 1.32B, with a P/E ratio of -16.74.

As of 2025-12-04, Beta Bionics(BBNX) stock has fluctuated between $29.56 and $31.51. The current price stands at $30.00, placing the stock +1.5% above today's low and -4.8% off the high.

Beta Bionics(BBNX) shares are trading with a volume of 644.75K, against a daily average of 730.14K.

During the past year, Beta Bionics(BBNX) stock moved between $8.89 at its lowest and $32.71 at its peak.

During the past year, Beta Bionics(BBNX) stock moved between $8.89 at its lowest and $32.71 at its peak.

BBNX News

TipRanks 2h
Top Executives at Beta Bionics, Inc. Cash Out on Stock Sales

New insider activity at Beta Bionics, Inc. ( (BBNX) ) has taken place on December 4, 2025. TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-...

Nasdaq 4d
BBNX Crosses Above Average Analyst Target

In recent trading, shares of Beta Bionics Inc (Symbol: BBNX) have crossed above the average analyst 12-month target price of $31.30, changing hands for $31.34/s...

BBNX Crosses Above Average Analyst Target

Analyst ratings

90%

of 10 ratings
Buy
90%
Hold
10%
Sell
0%

People also own

Based on the portfolios of people who own BBNX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.